In a significant announcement that could reshape the landscape of financial regulation, the Securities and Exchange Commission (SEC) has unveiled its examination priorities for 2025. This comprehensive list, released by the SEC’s Division of Examinations, aims to inform registered investment advisers, investment companies, and broker-dealers about the potential areas of scrutiny in the upcoming year.


With a changing presidential administration on the horizon, the SEC’s focus could shift significantly. However, as history suggests, many of the priorities outlined by the Division are likely to persist, irrespective of political changes. Therefore, it is crucial for stakeholders to review these priorities meticulously and seek counsel if necessary.


Investment Advisers: A Continued Focus

The SEC’s Division of Examinations will continue its tradition of prioritizing the examination of investment advisers, with a particular focus on those who have never been examined, newly-registered advisers, and those who haven’t been reviewed recently. In 2025, the Division will emphasize fiduciary standards, compliance programs, and private fund advisers.


Fiduciary Duties

Investment advisers must adhere to fiduciary standards of conduct, acting in the best interests of their clients at all times. The Division will scrutinize investment advice, especially concerning high-cost products, unconventional instruments, and assets sensitive to market conditions. Dual-registrants and advisers with affiliated broker-dealers will also face increased examination.


Compliance Programs

Compliance with Rule 206(4)-7 under the Investment Advisers Act of 1940 remains a priority. The Division will evaluate core compliance areas such as marketing, valuation, and trading. Special attention will be given to advisers integrating AI into their operations or those dealing with illiquid assets.


Private Fund Advisers

The Division will continue to focus on private fund advisers, particularly those employing strategies sensitive to market volatility. The review will include conflicts of interest disclosures and adherence to recent regulatory amendments.


Broker-Dealers: Upholding Standards

Broker-dealers will face rigorous examinations concerning Regulation Best Interest (Reg BI) and Form CRS obligations. Financial responsibility and trading-related practices will also be under scrutiny.


Regulation Best Interest

The Division will assess whether broker-dealers make recommendations in the best interests of their clients, focusing on complex and high-risk products. Automated recommendations and those made to specific investor groups will also be reviewed.


Form CRS

Broker-dealers must provide a “relationship summary” within Form CRS to all retail investors, detailing services, fees, and conflicts of interest. The Division will review these summaries for accuracy and completeness.


Financial Responsibility and Trading Practices

Examinations will prioritize compliance with financial responsibility rules and trading practices, including those related to pre-IPO companies and private shares.


Key Risk Areas

The SEC’s 2025 priorities also highlight cybersecurity, compliance with recent amendments, and the use of financial technologies as key risk areas.


Cybersecurity

Ensuring robust cybersecurity practices remains a top priority. The Division will focus on policies, governance, and third-party risks to prevent service interruptions and protect investor information.


Compliance with Recent Amendments

The Division will assess compliance with new data breach notification standards and regulations affecting data protection and trading practices.


Financial Technologies and AI

With AI’s rise, the Division will scrutinize its use in investment tools and digital engagement practices. Firms must ensure AI representations are accurate and that adequate monitoring and supervision are in place.


Crypto Assets

Crypto assets remain a priority, with examinations focusing on compliance practices and risk disclosures related to crypto securities.


These priorities, while not exhaustive, serve as a reference for potential risks and compliance areas. For more detailed insights, the original article by Eric T. Mikkelson and Carissa Occhipinto can be accessed here.


More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Telehealth: Bridging the Gap in Healthcare Access

Telehealth has emerged as a vital tool in providing equitable healthcare access by increasing the availability of specialists and reducing transportation barriers.

By |December 24, 2024|Categories: Article, Healthcare, Technology|Tags: , |0 Comments

Revolutionizing Liver Cancer Diagnosis: An Emerging Market Potential

Liver cancer continues to be a significant health challenge globally, ranking as one of the leading causes of cancer-related deaths.

By |December 24, 2024|Categories: Article, Healthcare, Market Analysis|Tags: , |0 Comments

World Cities Day 2024: A Global Movement Towards Sustainable Urban Futures

In the spirit of World Cities Day, celebrated on October 31st, cities worldwide are embracing the theme "Youth Leading Climate and Local Action for Cities." This theme underscores the pivotal role of young leaders in driving sustainable urban solutions, a movement gaining momentum through community-led initiatives and progressive policies.

The Road Ahead: Self-Driving Cars Reshape the Automotive Industry

"Goldman Sachs envisions a scenario where AV sales, particularly those with Level 3 automation or higher, could account for 60% of all light vehicle sales by 2040. Even in a less optimistic scenario, AVs are expected to comprise nearly 40% of new sales."

Semaglutide: A Promising Ally Against Alzheimer’s?

A groundbreaking study by researchers at Case Western Reserve School of Medicine reveals semaglutide, a common diabetes and weight-loss drug, may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes.

By |December 23, 2024|Categories: Article, Health, Research|Tags: |0 Comments

Revolutionizing Healthcare: The AI Transformation in Louisiana

In the heart of Louisiana, a digital revolution is underway, reshaping the landscape of healthcare diagnostics with the power of artificial intelligence (AI). AI is not just a tool but a transformative force, enhancing diagnostic accuracy, improving patient outcomes, and reducing costs.